To investigate the basis of polycystic ovary syndrome, we examined the responses of patients to nafarelin, a specific gonadotropin-releasing-hormone agonist, given to stimulate pituitary and gonadal secretion. We compared 16 normal women in the follicular phase, 5 normal men, 8 women with polycystic ovary syndrome, and 1 woman with polycystic ovary syndrome caused by a 3 beta-hydroxysteroid dehydrogenase deficiency. After 100 micrograms of nafarelin was given subcutaneously, serum follicle-stimulating hormone and luteinizing hormone increased rapidly to peak levels within four hours. The women with polycystic ovary syndrome had a pattern similar to that of the men, with greater early luteinizing-hormone responses (30 minutes to 1 hour) and lower peak follicle-stimulating-hormone responses than normal women (P less than 0.05). Patients with polycystic ovary syndrome responded to gonadotropin stimulation with normal to increased production of plasma estrogens and increased levels of androstenedione at 16 to 24 hours (P less than 0.05). Elevated production of 17 alpha-hydroxyprogesterone was found in all the women with polycystic ovary syndrome and in the men. These abnormal responses were unchanged by pretreatment with dexamethasone to suppress adrenal function. In the patient with the 3 beta-hydroxysteroid dehydrogenase deficiency, both basal and stimulated plasma levels of delta 5-3 beta-hydroxysteroids before the enzymatic block were elevated, whereas plasma levels of 17 alpha-hydroxyprogesterone and androstenedione--the steroids immediately beyond the block--were low. We conclude that women with polycystic ovary syndrome have masculinized pituitary and ovarian responses to stimulation by nafarelin. Our findings suggest that the regulation of the ovarian 17-hydroxylase and C-17,20-lyase activities is abnormal in such women.
Source Information
Department of Obstetrics/Gynecology, University of Chicago Pritzker School of Medicine, IL.
This article has been cited by other articles:
Hugues, J.-N., Theron-Gerard, L., Coussieu, C., Pasquier, M., Dewailly, D., Cedrin-Durnerin, I.
(2009). Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels. Hum Reprod
0: dep378v1-dep378
[Abstract][Full Text]
Sir-Petermann, T., Codner, E., Perez, V., Echiburu, B., Maliqueo, M., Ladron de Guevara, A., Preisler, J., Crisosto, N., Sanchez, F., Cassorla, F., Bhasin, S.
(2009). Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
94: 1923-1930
[Abstract][Full Text]
Doi, S. A. R.
(2008). Neuroendocrine Dysfunction in PCOS: A Critique of Recent Reviews. Clin Med Res
6: 47-53
[Full Text]
Abbott, D. H, Barnett, D. K, Levine, J. E, Padmanabhan, V., Dumesic, D. A, Jacoris, S., Tarantal, A. F
(2008). Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys. Biol. Reprod.
79: 154-163
[Abstract][Full Text]
Tee, M. K., Dong, Q., Miller, W. L.
(2008). Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis. Endocrinology
149: 2667-2677
[Abstract][Full Text]
Samandari, E., Kempna, P., Nuoffer, J.-M., Hofer, G., Mullis, P. E, Fluck, C. E
(2007). Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3{beta}-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities. J Endocrinol
195: 459-472
[Abstract][Full Text]
Pasquali, R., Patton, L., Pocognoli, P., Cognigni, G. E., Gambineri, A.
(2007). 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
92: 4208-4217
[Abstract][Full Text]
Kempna, P., Hofer, G., Mullis, P. E., Fluck, C. E.
(2007). Pioglitazone Inhibits Androgen Production in NCI-H295R Cells by Regulating Gene Expression of CYP17 and HSD3B2. Mol. Pharmacol.
71: 787-798
[Abstract][Full Text]
Codner, E., Soto, N., Lopez, P., Trejo, L., Avila, A., Eyzaguirre, F. C., Iniguez, G., Cassorla, F.
(2006). Diagnostic Criteria for Polycystic Ovary Syndrome and Ovarian Morphology in Women with Type 1 Diabetes Mellitus. J. Clin. Endocrinol. Metab.
91: 2250-2256
[Abstract][Full Text]
Zanolin, M. E., Tosi, F., Zoppini, G., Castello, R., Spiazzi, G., Dorizzi, R., Muggeo, M., Moghetti, P.
(2006). Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome: Assessment by principal component analysis in young hyperandrogenic women. Diabetes Care
29: 372-378
[Abstract][Full Text]
Diamanti-Kandarakis, E., Piperi, C.
(2005). Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update
11: 631-643
[Abstract][Full Text]
Wickenheisser, J. K., Nelson-DeGrave, V. L., Hendricks, K. L., Legro, R. S., Strauss, J. F. III, McAllister, J. M.
(2005). Retinoids and Retinol Differentially Regulate Steroid Biosynthesis in Ovarian Theca Cells Isolated from Normal Cycling Women and Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
90: 4858-4865
[Abstract][Full Text]
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., Melner, M. H.
(2005). Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family. Endocr. Rev.
26: 525-582
[Abstract][Full Text]
Wickenheisser, J. K., Nelson-DeGrave, V. L., McAllister, J. M.
(2005). Dysregulation of Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
90: 1720-1727
[Abstract][Full Text]
Petermann, T. S., Cartes, A., Maliqueo, M., Vantman, D., Gutierrez, C., Toloza, H., Echiburu, B., Recabarren, S.E.
(2004). Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study. Hum Reprod
19: 2742-2747
[Abstract][Full Text]
McCartney, C. R., Bellows, A. B., Gingrich, M. B., Hu, Y., Evans, W. S., Marshall, J. C., Veldhuis, J. D.
(2004). Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome. Am. J. Physiol. Endocrinol. Metab.
286: E902-E908
[Abstract][Full Text]
Wickenheisser, J. K., Nelson-DeGrave, V. L., Quinn, P. G., McAllister, J. M.
(2004). Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1. Mol. Endocrinol.
18: 588-605
[Abstract][Full Text]
De Leo, V., la Marca, A., Petraglia, F.
(2003). Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome. Endocr. Rev.
24: 633-667
[Abstract][Full Text]
Fassnacht, M., Schlenz, N., Schneider, S. B., Wudy, S. A., Allolio, B., Arlt, W.
(2003). Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
88: 2760-2766
[Abstract][Full Text]
Ferin, M., Morrell, M., Xiao, E., Kochan, L., Qian, F., Wright, T., Sauer, M.
(2003). Endocrine and Metabolic Responses to Long-Term Monotherapy with the Antiepileptic Drug Valproate in the Normally Cycling Rhesus Monkey. J. Clin. Endocrinol. Metab.
88: 2908-2915
[Abstract][Full Text]
Cheung, A. P., Pride, S. M., Yuen, B. H., Sy, L.
(2002). In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome. Hum Reprod
17: 2540-2547
[Abstract][Full Text]
Barnes, R. B., Namnoum, A. B., Rosenfield, R. L., Layman, L. C.
(2002). The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: Clinical studies in a patient with isolated FSH deficiency and multicystic ovaries: Case report. Hum Reprod
17: 88-91
[Abstract][Full Text]
Nelson, V. L., Qin, K.-n., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F. III, McAllister, J. M.
(2001). The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
86: 5925-5933
[Abstract][Full Text]
Ibáñez, L., DiMartino-Nardi, J., Potau, N., Saenger, P.
(2000). Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?. Endocr. Rev.
21: 671-696
[Abstract][Full Text]
Martens, J. W. M., Geller, D. H., Arlt, W., Auchus, R. J., Ossovskaya, V. S., Rodriguez, H., Dunaif, A., Miller, W. L.
(2000). Enzymatic Activities of P450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
85: 4338-4346
[Abstract][Full Text]
Lobo, R. A., Carmina, E.
(2000). The Importance of Diagnosing the Polycystic Ovary Syndrome. ANN INTERN MED
132: 989-993
[Abstract][Full Text]
Chang, P. L., Lindheim, S. R., Lowre, C., Ferin, M., Gonzalez, F., Berglund, L., Carmina, E., Sauer, M. V., Lobo, R. A.
(2000). Normal Ovulatory Women with Polycystic Ovaries Have Hyperandrogenic Pituitary-Ovarian Responses To Gonadotropin-Releasing Hormone-Agonist Testing. J. Clin. Endocrinol. Metab.
85: 995-1000
[Abstract][Full Text]
la Marca, A., Egbe, T. O., Morgante, G., Paglia, T., Ciani, A., De Leo, V.
(2000). Metformin treatment reduces ovarian cytochrome P-450c17{alpha} response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Hum Reprod
15: 21-23
[Abstract][Full Text]
(1999). New Insight into the Molecular Basis of 3{beta}-Hydroxysteroid Dehydrogenase Deficiency: Identification of Eight Mutations in the HSD3B2 Gene in Eleven Patients from Seven New Families and Comparison of the Functional Properties of Twenty-Five Mutant Enzymes. J. Clin. Endocrinol. Metab.
84: 4410-4425
[Abstract][Full Text]
Ciotta, L., De Leo, V., Galvani, F., La Marca, A., Cianci, A.
(1999). Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. Hum Reprod
14: 2951-2958
[Abstract][Full Text]
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., Giudice, L. C.
(1999). The Insulin-Related Ovarian Regulatory System in Health and Disease. Endocr. Rev.
20: 535-582
[Abstract][Full Text]
Nelson, V. L., Legro, R. S., Strauss, J. F. III, McAllister, J. M.
(1999). Augmented Androgen Production Is a Stable Steroidogenic Phenotype of Propagated Theca Cells from Polycystic Ovaries. Mol. Endocrinol.
13: 946-957
[Abstract][Full Text]
Vuguin, P., Linder, B., Rosenfeld, R. G., Saenger, P., DiMartino-Nardi, J.
(1999). The Roles of Insulin Sensitivity, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-1 and -3 in the Hyperandrogenism of African-American and Caribbean Hispanic Girls with Premature Adrenarche. J. Clin. Endocrinol. Metab.
84: 2037-2042
[Abstract][Full Text]
Banerjee, S., Raghavan, S., Wasserman, E. J., Linder, B. L., Saenger, P., DiMartino-Nardi, J.
(1998). Hormonal Findings in African-American and Caribbean Hispanic Girls With Premature Adrenarche: Implications for Polycystic Ovarian Syndrome. Pediatrics
102: e36-e36
[Abstract][Full Text]
Hayes, F. J., Taylor, A. E., Martin, K. A., Hall, J. E.
(1998). Use of a Gonadotropin-Releasing Hormone Antagonist as a Physiologic Probe in Polycystic Ovary Syndrome: Assessment of Neuroendocrine and Androgen Dynamics. J. Clin. Endocrinol. Metab.
83: 2343-2349
[Abstract][Full Text]
Nestler, J. E., Jakubowicz, D. J.
(1997). Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17{alpha} Activity and Serum Androgens. J. Clin. Endocrinol. Metab.
82: 4075-4079
[Abstract][Full Text]
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., Polonsky, K. S.
(1997). Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
82: 2108-2116
[Abstract][Full Text]
Barnes, R. B., Ehrmann, D. A.
(1997). Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor. J. Clin. Endocrinol. Metab.
82: 1746-1748
[Full Text]
Ehrmann, D. A., Cavaghan, M. K., Imperial, J., Sturis, J., Rosenfield, R. L., Polonsky, K. S.
(1997). Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab.
82: 524-530
[Abstract][Full Text]
Previous
